Prognostic and Clinical Value of Interleukin 6 and CD45⁺CD14⁺ Inflammatory Cells with PD-L1⁺/PD-L2⁺ Expression in Patients with Different Manifestation of Ovarian Cancer

Figure 3

Levels of IL-6 (pg/ml) in the peritoneal fluid of patients with ovarian cancer and in the group with benign ovarian tumors.